Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Arthritis Care & Research|March 26, 2014
Sustainability of rituximab therapy in different treatment strategies: results of a 3-year followup of a German biologics registerAdrian Richter, Anja Strangfeld, Peter Herzer, et al.
Annals of the Rheumatic Diseases|December 3, 2013
Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximabJoachim Listing, Jörn Kekow, Bernhard Manger, et al.
Clinical and Experimental Rheumatology|July 10, 2019
Trends in employment and hospitalisation in patients with Sjögren's syndrome 1996-2016: results from the German National databaseJohanna Callhoff, Katja Thiele, Thomas Dörner, et al.
Arthritis Care & Research|September 30, 2021
Association Between Rheumatoid Arthritis Disease Activity and Periodontitis Defined by Tooth Loss: Longitudinal and Cross-Sectional Data From Two Observational StudiesKatinka Albrecht, Paola de Pablo, Thorsten Eidner, et al.
Seminars in Arthritis and Rheumatism|October 15, 2018
Are prognostic factors adequately selected to guide treatment decisions in patients with rheumatoid arthritis? A collaborative analysis from three observational cohortsLisa Baganz, Adrian Richter, Katinka Albrecht, et al.
Rheumatology International|June 29, 2020
Trends in idiopathic inflammatory myopathies: cross-sectional data from the German National DatabaseKatinka Albrecht, Dörte Huscher, Johanna Callhoff, et al.
Rheumatology International|November 11, 2017
Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology databaseKatinka Albrecht, Dörte Huscher, Frank Buttgereit, et al.
Arthritis Research & Therapy|September 11, 2020
The prevalence and impact of comorbidities on patients with axial spondyloarthritis: results from a nationwide population-based studyImke Redeker, Johanna Callhoff, Falk Hoffmann, et al.
Annals of the Rheumatic Diseases|May 1, 2015
Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA)Jens Klotsche, Martina Niewerth, Johannes-Peter Haas, et al.
Rheumatology (Oxford, England)|March 27, 2012
Long-term outcome of patients with JIA treated with etanercept, results of the biologic register JuMBOKirsten Minden, Martina Niewerth, Angela Zink, et al.
Pageof 11